QT
PASG icon

Quantbot Technologies’s Passage Bio PASG Stock Holding History

Quantbot Technologies’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-185
Closed -$4K – 2001
2022
Q3 		$4K Sell
185
-5
-3% -$197 ﹤0.01% 1489
2022
Q2 		$8K Sell
190
-125
-40% -$5.84K ﹤0.01% 1554
2022
Q1 		$19K Sell
315
-10
-3% -$824 ﹤0.01% 1369
2021
Q4 		$41K Buy
325
+35
+12% +$5.72K ﹤0.01% 1077
2021
Q3 		$57K Buy
290
+240
+480% +$57.2K ﹤0.01% 1083
2021
Q2 		$13K Buy
+50
New +$15.5K ﹤0.01% 1281

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Quantbot Technologies's PASG Position: Q4 2022 in Review

Quantbot Technologies sold out of Passage Bio (PASG) in Q4 2022, closing a stake of 185 shares — an estimated $4K sold.

Quantbot Technologies first reported a position in PASG in Q2 2021 and held it in 6 quarters. The position peaked at $57K in Q3 2021. 67 funds tracked by Wall St. Rank hold PASG as of Q4 2022.

  • Quantbot Technologies reported no remaining Passage Bio position as of Q4 2022 after selling out during the quarter.
  • Quantbot Technologies sold 185 Passage Bio shares in Q4 2022, an estimated $4K.
  • Quantbot Technologies first reported a position in Passage Bio in Q2 2021 and held it in 6 quarters.
  • Quantbot Technologies's Passage Bio position peaked at $57K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Passage Bio as of Q4 2022.

Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.